Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
BioLineRx Ltd. has 2 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either BioLineRx Ltd.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
BioLineRx Ltd.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Manufacturing
Prev close 2.51 · gapped below the open, never looked back. High/low 2.51 at 12:15 pm ET, 2.48 at 11:15 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In accordance with the license agreement of motixafortide with Biokine (as amended), the Company is required to pay Biokine a payment of 20 % of amounts received as consideration in connection with any sublicensing or sale of the licensed technology. Biokine is also eligible to receive up to a total of $ 2.5 million in future milestone payments.”
FILING20-F0001178913-26-001581cik 0001498403
“the Company and Hemispherian entered into a Collaboration and Shareholders Agreement (the "Agreement with Hemispherian"), which governs the ownership, governance, funding, administration, and related operational and commercial terms of a new company (Tetragon) established by the Company and Hemispherian”
FILING20-F0001178913-26-001581cik 0001498403
“pursuant to which the Company granted HST an exclusive, royalty-bearing, sublicensable license to develop and commercialize motixafortide in Asia (other than Israel and certain other countries) (collectively, the "Gloria Territory") and to engage and authorize Gloria to perform services under the Gloria License Agreement in the Gloria Territory.”
FILING20-F0001178913-26-001581cik 0001498403
“pursuant to which the Company granted HST an exclusive, royalty-bearing, sublicensable license to develop and commercialize motixafortide in Asia (other than Israel and certain other countries) (collectively, the "Gloria Territory") and to engage and authorize Gloria to perform services under the Gloria License Agreement in the Gloria Territory.”
FILING20-F0001178913-26-001581cik 0001498403
“Additionally, the Company is eligible to receive tiered double-digit royalties (ranging from 18 - 23 %) on aggregate net sales of motixafortide on a country-by-country basis until the longer of (i) fifteen years from the date of the first sale of motixafortide by the Ayrmid Licensee in such country,”
FILING20-F0001178913-26-001581cik 0001498403
Watchlist prices, news filtered to it, and its next report on your desk.
BLRX (BioLineRx Ltd.) has 2 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.